Advanced search
1 file | 105.82 KB

A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer

(2010) ONCOLOGY. 78(3-4). p.267-270
Author
Organization
Keywords
Toxicity, Chemotherapy, Non-small cell lung cancer, CLINICAL-TRIALS, Gemcitabine, Carboplatin, CISPLATIN, METAANALYSIS, GEMCITABINE/CARBOPLATIN, CHEMOTHERAPY, TOXICITY

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 105.82 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Surmont, Veerle, JGJV Aerts, RJ van Klaveren, K Tournoy, KY Tan, RM Vernhout, PIM Schmitz, C Legrand, HC Hoogsteden, and JP van Meerbeeck. 2010. “A Randomized Phase II Study Comparing Two Schedules of the 21-day Regimen of Gemcitabine and Carboplatin in Advanced Non-small Cell Lung Cancer.” Oncology 78 (3-4): 267–270.
APA
Surmont, V., Aerts, J., van Klaveren, R., Tournoy, K., Tan, K., Vernhout, R., Schmitz, P., et al. (2010). A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer. ONCOLOGY, 78(3-4), 267–270.
Vancouver
1.
Surmont V, Aerts J, van Klaveren R, Tournoy K, Tan K, Vernhout R, et al. A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer. ONCOLOGY. 2010;78(3-4):267–70.
MLA
Surmont, Veerle, JGJV Aerts, RJ van Klaveren, et al. “A Randomized Phase II Study Comparing Two Schedules of the 21-day Regimen of Gemcitabine and Carboplatin in Advanced Non-small Cell Lung Cancer.” ONCOLOGY 78.3-4 (2010): 267–270. Print.
@article{1186503,
  author       = {Surmont, Veerle and Aerts, JGJV and van Klaveren, RJ and Tournoy, K and Tan, KY and Vernhout, RM and Schmitz, PIM and Legrand, C and Hoogsteden, HC and van Meerbeeck, JP},
  issn         = {0030-2414},
  journal      = {ONCOLOGY},
  keywords     = {Toxicity,Chemotherapy,Non-small cell lung cancer,CLINICAL-TRIALS,Gemcitabine,Carboplatin,CISPLATIN,METAANALYSIS,GEMCITABINE/CARBOPLATIN,CHEMOTHERAPY,TOXICITY},
  language     = {eng},
  number       = {3-4},
  pages        = {267--270},
  title        = {A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer},
  url          = {http://dx.doi.org/10.1159/000315733},
  volume       = {78},
  year         = {2010},
}

Altmetric
View in Altmetric
Web of Science
Times cited: